Takeda Pharmaceutical Co Ltd
TSE:4502
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
JP |
|
Mirza International Ltd
NSE:MIRZAINT
|
IN |
|
FIH Mobile Ltd
F:FW3
|
TW |
|
Tower Semiconductor Ltd
NASDAQ:TSEM
|
IL |
|
Kiwi Property Group Ltd
NZX:KPG
|
NZ |
|
Terago Inc
TSX:TGO
|
CA |
|
Iridium Communications Inc
NASDAQ:IRDM
|
US |
|
Supreme Engineering Ltd
NSE:SUPREMEENG
|
IN |
|
Catana Group SA
PAR:CATG
|
FR |
|
A
|
AIA Group Ltd
F:7A2
|
HK |
|
Imugene Ltd
ASX:IMU
|
AU |
|
C
|
Canada Goose Holdings Inc
F:1GC
|
CA |
|
Telkom Indonesia (Persero) Tbk PT
IDX:TLKM
|
ID |
|
EnerSys
NYSE:ENS
|
US |
|
Verint Systems Inc
NASDAQ:VRNT
|
US |
|
Borregaard ASA
OSE:BRG
|
NO |
|
Capricor Therapeutics Inc
NASDAQ:CAPR
|
US |
|
C
|
CCL Industries Inc
OTC:CCLLF
|
CA |
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
AU |
|
Vipul Ltd
NSE:VIPULLTD
|
IN |
|
J
|
JBT Marel Corp
XMUN:JBT
|
US |
|
I
|
ING Bank Slaski SA
WSE:ING
|
PL |
|
T
|
Trillion Energy International Inc
CNSX:TCF
|
CA |
|
BEC World PCL
OTC:BECVY
|
TH |
Dividends
Dividend Yield
Takeda Pharmaceutical Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Takeda Pharmaceutical Co Ltd
Takeda Pharmaceutical Co Ltd have increased by 66%.
Payout Ratio
Takeda Pharmaceutical Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Takeda Pharmaceutical Co Ltd is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Takeda Pharmaceutical Co Ltd
| Average Annual Return | 6.78% |
| Standard Deviation of Annual Returns | 18.15% |
| Max Drawdown | -19% |
| Market Capitalization | 7.5T JPY |
| Shares Outstanding | 1 591 260 000 |
| Percentage of Shares Shorted |
N/A
|
